Low-Dose Linezolid Appears To Be Tied To Improved Outcomes, Fewer Adverse Events In Patients With Multidrug-Resistant TB Infection, Analysis Indicates

Infectious Disease Advisor (11/17, Lopez) reports, “Compared with the standard dose, low-dose linezolid was found to be associated with improved outcomes, increased tolerability to longer treatment durations, and fewer adverse events (AEs) in patients wit...